Notice No.   20221212-1   Notice Date   12 Dec 2022
Category   Company related   Segment   Equity
Subject   Buyback of equity shares of Jenburkt Pharmaceuticals Limited (Scrip code: 524731)
Attachments   Public Announcement.pdf ;

Trading Members are hereby informed that Jenburkt Pharmaceuticals Limited (Scrip code: 524731) has announced buyback of its fully paid-up equity shares of face value of Rs. 10/- each from the Open Market through electronic trading mechanism of the Exchange. The Maximum Buyback Price would not exceed Rs. 702/- (Rupees seven hundred and two only) per equity share payable in cash for an aggregate amount not exceeding Rs. 11.60 crores


1.       Proposed timetable for buyback:


Date of Opening of the Buyback

Tuesday, December 13, 2022

Last Date for the Buyback

Earlier of:

(a)    6 months from the date of the opening of the Buy-back or

(b)    when the Company completes the Buy-back by deploying the amount equivalent to the Maximum Buy-back Size; or

(c)     at such earlier date as may be determined by the Board / or its duly authorized Executive Committee, after giving notice of such earlier closure, subject to the Company having deployed an amount equivalent to the Minimum Buy-back Size (even if the Maximum Buy-back Size has not been reached or the Maximum Buy-back Shares have not been bought back), however, that all payment obligations relating to the shares bought back shall be completed before the last date for the Buy-back.


2.       Broker Members for buyback:


The company has appointed the following BSE Trading Members through whom the purchases and settlement on account of the buyback would be made:


DAM Capital Advisors Limited

One BKC, Tower C, 15 Floor, Unit No. 1511,

Bandra Kurla Complex, Bandra (East),

Mumbai 400 051, Maharashtra, India

Tel.: +1 22 4202 2500;

Fax: +91 22-4202 2504

Contact Person: Mr. Rajesh Tekadiwala


Clearing No: 0623



3.       Details of Shares held in DEMAT Form.


The Trading Members may note that the Equity Shares held in DEMAT form can be offered for Buyback to the Company in rolling settlement, as per details mentioned below:


Scrip Code


Market Lot

1 Share

Scrip ID



4.       Circuit Filters, Margins, Capital Adequacy Norms, Auction, Close out, Arbitration, etc. are applicable in case of buyback as in the case of the normal trading.


5.       Institutional Investors are allowed to participate in the buyback.


6.       Please note that, settlement will be with normal equity cash segment trades and market type for delivery will be “Normal” equity cash segment


7.       The documents are available in Department of Corporate Services for inspection. In case of any queries /clarifications on the scheme of buyback, Trading Members may please contact the under mentioned persons:


·         Merchant Banker to the Buyback:

DAM Capital Advisors Limited

One BKC, Tower C, 15 Floor, Unit No. 1511,

Bandra Kurla Complex, Bandra (East),

Mumbai 400 051, Maharashtra, India

Tel.: +1 22 4202 2500;

Fax: +91 22-4202 2504

Contact Person: Nidhi Gupta / Gunjan Jain



SEBI Registration No.: MB/INM000011336


·         At the Company:

Name: Ashish R. Shah

Designation: Company Secretary & Compliance Officer

Address: Nirmala Apartments, 93, Jayprakash Road, Andheri West,

Mumbai-400 058

Tel: 022-67603603

Email id:


·         Registrar to the buyback and Investor service centre:

Bigshare Services Private Limited

Office No S6-2, 6th Floor, Pinnacle Business

Park, Next to Ahura Centre, Mahakali

Caves Road, Andheri (East) Mumbai – 400093

Tel. No.: 022 - 62638200 

Contact Person: Mr. Swapnil Kate




·         At the Exchange:

Clearing & Settlement Department -

Mr. Nilesh Shah/Ajay Darji - Extn: 022-22728468/5163/5628/8223/5784

        Email Id:


Trading Department -

Trading Operations - Extn: 022-2272- 8376 (For Trading Related)


Help desk - Extn: 61363100 (Hunting) (For BOLT System)


Listing Operations Department –

Mr. Raghavendra Bhat Extn: 022-2272-8915/8995 (For General Queries)



Rupal Khandelwal

Assistant General Manager

December 12, 2022